This August 2020 photo provided by Dr. Se-Jin Lee shows a normal mouse and a “twice-muscled” mouse developed at the The Jackson Laboratory of the University of Connecticut School of Medicine in Farmington, Conn. Findings published on Monday, Sept. 7, 2020, show that muscle-bound mice, similar to the one pictured, held on to their bodybuilder-type physiques during a one month space mission. (Dr. Se-Jin Lee/University of Connecticut School of Medicine via AP)
By Marcia Dunn
Bulked-up, mutant "mighty mice" held onto their muscle during a monthlong stay at the International Space Station, returning to Earth with ripped bodybuilder physiques, scientists reported Monday.
The findings hold promise for preventing muscle and bone loss in astronauts on prolonged space trips like Mars missions, as well as people on Earth who are confined to a bed or need wheelchairs.
A research team led by Dr. Se-Jin Lee of the Jackson Laboratory in Connecticut sent 40 young female black mice to the space station in December, launching aboard a SpaceX rocket.
In a paper published in the Proceedings of the National Academy of Sciences, Lee said the 24 regular untreated mice lost considerable muscle and bone mass in weightlessness as expected — up to 18%.
But the eight genetically engineered "mighty mice" launched with double the muscle maintained their bulk. Their muscles appeared to be comparable to similar "mighty mice" that stayed behind at NASA's Kennedy Space Center.
In addition, eight normal mice that received "mighty mouse" treatment in space returned to Earth with dramatically bigger muscles. The treatment involves blocking a pair of proteins that typically limit muscle mass.
A SpaceX capsule brought all 40 mice back in good condition, parachuting into the Pacific off the California coast in January. Some of the ordinary mice were injected with the "mighty mice" drug after returning and quickly built up more muscle than their untreated companions, Lee said.
The scientists completed the experiment just as the coronavirus was hitting the U.S.
"The only silver lining of COVID is that we had time to write it up very intensively" and submit the results for publication, said Dr. Emily Germain-Lee of Connecticut Children's Medical Center, Lee's wife who also took part in the study. Both are affiliated with the University of Connecticut.
While encouraged by their findings, the couple said much more work needs to be done before testing the drug on people to build up muscle and bone, without serious side effects.
"We're years away. But that's how everything is when you go from mouse to human studies," Germain-Lee said.
Lee said the experiment pointed out other molecules and signaling pathways worth investigating — "an embarrassment of riches ... so many things we'd like to pursue." His next step: possibly sending more "mighty mice" to the space station for an even longer stay.
Three NASA astronauts looked after the space mice, performing body scans and injections: Christina Koch and Jessica Meir, who performed the first all-female spacewalk last fall, and Andrew Morgan. They are listed as co-authors.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
As we prepare to ring in the new year, COVID cases are hitting an all-time high. Dr. Anthony Fauci has said the safest way to celebrate would be a small gathering with vaccinated family members only... far from the large, flashy parties from a few years ago. Dr. Christina Johns, senior medical advisor at PM Pediatrics, joins Cheddar News to discuss how to celebrate safely.
Jurors in the trial against Theranos CEO Elizabeth Holmes have entered day six of deliberations. Holmes is accused of lying to investors about the functionality of a newly developed blood-testing technology. Andrew George, partner at Baker Botts, joined Cheddar to break down key points in the case and what the jury might be considering during their deliberations. He also noted that the rest of Silicon Valley, including Holmes' business partner, Ramesh "Sunny" Balwani, who is facing identical charges, is closely watching the outcome of deliberations — as it could set the tone for future regulations and Balwani's own trial.
According to researchers, the state of California's cap-and-trade program is currently being undermined by forest fires caused primarily by climate change. Over the past few years, trees that were set aside for the program have been releasing carbon as they continue to burn in fires. Climate Researcher and Policy Director at CarbonPlan Danny Cullenward, joined Cheddar to discuss more.
The CDC's latest update to its COVID-19 quarantine guidelines reduces the isolation period from ten days to just five for people who test positive but are asymptomatic. Dr. Bayo Curry-Winchell, regional clinical director at Carbon Health, spoke to Cheddar's Baker Machado about the new guidance. She noted that while the reduced quarantine time "makes sense," the CDC should also require that a person test negative after their quarantine and before interacting with the public. "There is science behind it. We know that the majority of illness happens, or transmission, one to two days before the onset of symptoms and then two to three days as you have symptoms. So there is science behind the reducement of the actual five days," she said.
Prices at the pump this year reached a seven-year high, and a new forecast from GasBuddy shared with CNN predicts that gas prices will only continue to rise in 2022 and that the national average could even reach $4.00 a gallon; however, analysts at GasBuddy say anything could happen when it comes to gas prices in the future, as the pandemic has made it difficult to make any predictions about the economy. Consumer Energy Alliance federal policy advisor Michael Zehr joins Cheddar News' Closing Bell to discuss.
As the Omicron variant is fueling a surge in COVID-19 cases, parents and schools are faced with tough choices between absences and outbreaks. Matt Barnum, a national reporter at Chalkbeat, joins Cheddar News to discuss.
Ron Gutman, Co-CEO of Intrivo, joins Cheddar News to discuss how the company is creating a test and tech solution for Covid testing called 2Gather, and how it's using data-driven digital diagnostics to make these tests widely available and affordable.
